| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |